Outcome of treosulfan-based reduced-toxicity conditioning regimens for HSCT in high-risk patients with primary immune deficiencies
published in: Pediatric Transplantation
date of publication: 2018-07-11
Cites articles
There is nothing here
Article - wd:Q89544429